Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-23
1997-09-16
Jacobson, Dian C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435 696, 530383, 930100, A61K 3837, C07K 14755, C12N 1512
Patent
active
056681089
ABSTRACT:
Functional human factor VIII produced recombinantly is used in the treatment of human beings diagnosed to be deficient in factor VIII coagulant activity. Also provided are DNA isolates and expression vehicles encoding functional human factor VIII, as well as transformed host cells and processes for producing human factor VIII by use of recombinant DNA technology.
REFERENCES:
patent: Re32011 (1985-10-01), Zimmerman
patent: 4027013 (1977-05-01), Bick et al.
patent: 4069216 (1978-01-01), Shanbrom
patent: 4085095 (1978-04-01), Bick et al.
patent: 4093608 (1978-06-01), Iga et al.
patent: 4104266 (1978-08-01), Wickerhauser
patent: 4188318 (1980-02-01), Shanbrom
patent: 4221780 (1980-09-01), Cort
patent: 4289691 (1981-09-01), Rock et al.
patent: 4294826 (1981-10-01), Feldman
patent: 4341764 (1982-07-01), Wallace et al.
patent: 4348315 (1982-09-01), Blomback et al.
patent: 4359463 (1982-11-01), Rock
patent: 4361509 (1982-11-01), Zimmerman et al.
patent: 4387092 (1983-06-01), Liautaud et al.
patent: 4396601 (1983-08-01), Salser et al.
patent: 4399216 (1983-08-01), Axel et al.
patent: 4404131 (1983-09-01), Schwarz et al.
patent: 4495175 (1985-01-01), Chavin et al.
patent: 4508709 (1985-04-01), Amphlett et al.
patent: 4522751 (1985-06-01), Linnau et al.
patent: 4556558 (1985-12-01), Rubinstein
patent: 4614795 (1986-09-01), Chavin et al.
patent: 4632981 (1986-12-01), Bock et al.
patent: 4657894 (1987-04-01), Zimmerman et al.
patent: 4659805 (1987-04-01), Schilling, Jr.
patent: 4757006 (1988-07-01), Toole
patent: 4879226 (1989-11-01), Wallace et al.
patent: 4965199 (1990-10-01), Capon et al.
patent: 5004804 (1991-04-01), Kuo et al.
patent: 5101016 (1992-03-01), Zimmerman et al.
FDC Reports 50(18):T&G-12 (May 2, 1988).
Biotechnology Law Report 6:389-390 (Sept.-Oct 1987).
"Armour Starts Marketing Human Factor VIII, FDA-OK'd, Monoclonal-purified" Newswatch 7(21):5-6 (Nov 2, 1987).
"FDA Approves Rorer's Factor VIII Made Via Monoclonal Process" Genetic Technology News (Nexis Report) 7 (11) :2 (Nov. 1987).
Anderson et al., "Isolation and Characterization of Human Factor VIII: Molecular Forms in Commercial Factor VIII Concentrate, Cryoprecipitate, and Plasma" Proc. Natl. Acad. Sci. USA 83(9):2979-2983 (May 1986).
Beck et al., "Nucleotide Sequence and Exact Localization of the Neomycin Phosphotransferase Gene from Transposon Tn5" Gene 19(3):327-336 (1982).
Brownlee et al., "Clotting Factor VIII Cloned" Nature 312(5992):307 (Nov. 1984).
Choo et al., "Vectors for Expression and Amplification of cDNA in Mammalian Cells: Expression of Rat Phenylalanine Hydroxylase" DNA 5(6):529-537 (1986).
de Saint Vincent et al., "The Cloning and Reintroduction into Animal Cells of a Functional CAD Gene, a Dominant Amplifiable Genetic Marker" Cell 27(Part 1):267-277 (Dec. 1981).
Eaton et al., "Proteolytic Processing of Human Factor VIII. Correlation of Specific Cleavages by Thrombin, Factor Xa, and Activated Protein C with Activation and Inactivation of Factor VIII Coagulant Acitivity" Biochemistry 25(2):505-512 (1986).
Fass et al., "Monoclonal Antibodies to Porcine Factor VIII Coagulant and Their Use in the Isolation of Active Coagulant Protein" Blood 59(3):594-600 (Mar. 1982).
Fay et al., "The Effect of Carbohydrate Depletion on Procoagulant Activity and in Vivo Survival of Highly Purified Human Factor VIII" Biochimica et Biophysica Acta 800 (2):152-158 (Jul. 1984).
Fay et al., "Propolypeptide of von Willebrand Factor Circulates in Blood and is Identical to von Willebrand Antigen II" Science 232:995-998 (May 1986).
Fay et al., "Purification and Characterization of a Highly Purified Human Factor VIII Consisting of a Single Type of Polypeptide Chain" Proc. Natl. Acad. Sci. USA 79(23):7200-7204 (Dec. 1982).
Fay et al., "The Size of Human Factor VIII Heterodimers and the Effects Produced by Thrombin" Biochimica et Biophysica Acta 871(3):268-278 (June 1986).
Fulcher et al., "Characterization of the Human Factor VIII Procoagulant Protein with a Heterologous Precipitating Antibody" Proc. Natl. Acad. Sci. USA 79(5):1648-1652 (Mar. 1982).
Giri et al., "Comparative Studies of the Expression of Linked Escherichia coli gpt Gene and BPV-1 DNAs in Transfected Cells" Virology 127(2):385-396 (Jun. 1983).
Gitschier, "Characterization of the Human Factor VIII Gene" Nature 312(5992):326-330 (Nov. 1984).
Haber et al., "Chromosome-Mediated Transfer and Amplification of an Altered Mouse Dihydrofolate Reductase Gene" Somatic Cell Genetics 8(4):499-508 (1982).
Harris, "Isolation and Characterization of Low Molecular Weight Non-aggregated Antihemophelic Factor from Fresh Human Plasma" (Dissertation Abstract) (1979).
Hoyer et al., "The Effect of Thrombin on Human Factor VIII" J. Laboratory and Clin. Med. 97(1):50-64 (Jan. 1981).
Kaufman et al., "Amplification and Expression of Sequences Cotransfected with a Modular Dihydrofolate Reductase Complementary DNA Gene" J. Mol. Biol. 159:601-621 (1982).
Kaufman et al., "Construction of a Modular Dyhydrofolate Reductase cDNA Gene: Analysis of Signals Utilized for Efficient Expression" Molecular & Cellular Biology 2(11):1304-1319 (Nov. 1982).
Kaufman et al., "Selection and Amplification of Heterologous Genes Encoding Adenosine Deaminase in Mammalian Cells" Proc. Natl. Acad. Sci. USA 83(10):3136-3140 (May 1986).
Kaufman et al., "Site-specific Mutagenesis to Study the Structure and Function of Factor VIII" Journal of Cellular Biochemistry Supplement (UCLA Symposia on Molecular & Cellular Biology, Jan. 20, 1986-Feb. 15, 1986). New York: Alan R. Liss, Inc. vol. 10A:275 (Abstract E112) (1986).
Kempe et al., "Stable Mutants of Mammalian Vells that Overproduce the First Three Enzymes of Pyrimidine Nucleotide Biosynthesis" Cell 9(4):541-550 (Dec. 1976).
Knutson et al., "Porcine Factor VIII:C Prepared by Affinity Interaction with von Willebrand Factor and Heterologous Antibodies: Sodium Dodecyl Sulfate Polyacrylamide Gel analysis" Blood 59(3):615-624 (Mar. 1982).
Legaz et al., "Isolation and Characterization of Human Factor VIII (Antihemophilic Factor)" Journal of Biological Chemistry 248(11):3946-3955 (Jun. 1973).
Maddox, J., "Who will clone a chromosome?" Nature 312:306 (Nov. 1984).
McConlogue et al., "Molecular Cloning and Expression of the Mouse Ornithine Decarboxylase Gene" Proc. Natl. Acad. Sci. USA 81(2):540-544 (Jan. 1984).
Milbrandt et al., "Amplification of a Cloned Chinese Hamster Dihydrofolate Reductase Gene After Transfer into a Dihydrofolate Reductase-deficient Cell Line" Molecular & Cellular Biology 3(7):1274-1282 (21 Jul. 1983).
Murray et al., "Construction and Use of a Dominant, Selectable Marker: a Harvey Sarcoma Virus-dihydrofolate Reductase Chimera" Molecular & Cellular Biology 3(1):32-43 (Jan. 1983).
Norris et al., "Efficient Site-directed Mutagenesis by Simultaneous Use of Two Primers" Nucleic Acids Research 11(15):5103-5112 (1983).
Orr et al., "`Spacer` Function Implied for the Heavily Glycosylated Region of Factor VIII" Thrombosis Haemostasis 54(1):54 (Abstract S321) (1985).
Port, O., "Keeping Hemophiliacs Alive--with Less Danger" Business Week (Nexis Report) pp. 115 (Feb. 16, 1987).
Rhein, Jr. et al., "Freeing Hemophiliacs From the Risk of Aids" Business Week (Nexis Report) pp. 38 (April 13, 1987).
Ringold et al., "Co-expression and Amplification of Dihydrofolate Reductase CDNA and the Escherichia coli XGPRT Gene in Chinese Hamster Ovary Cells" Journal of Molecular & Applied Genetics 1(3):165-175 (1981).
Schoner et al., "The Organization of the Dihydrofolate Reductase Gene of Baby Hamster Kidney Fibroblasts" Nucleic Acids Research 9(23):6601-6614 (1981).
Simonsen et al., "Isolation and Expression of an Altered Mouse Dihydrofolate Reductase cDNA" Proc. Natl. Acad. Sci. USA 80(9):2495-2499 (1983).
Stel et al., "Detection of Factor VIII Coagulant Antigen in Human Liver Tissue" Nature 303:530-532 (Jun. 1983).
Toole et al., "A Large Region (Approximately Equal to 95 kDa) of Human Factor VIII is Dispensable for In Vitro Procoagulant Activity" Proc. Natl. Acad. Sci. USA 83(16):5939-5942 (Aug. 1986).
Toole et al., "Molecular Cloning of a cDNA Encoding Human Antihaemophilic Factor" Nature 312
Capon Daniel J.
Lawn Richard M.
Vehar Gordon A.
Wood William I.
Genentech Inc.
Hasak Janet E.
Jacobson Dian C.
LandOfFree
Preparation of functional human factor VIII and pharmaceutical t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of functional human factor VIII and pharmaceutical t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of functional human factor VIII and pharmaceutical t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-218183